PRTN3 and dermatomyositis: Therefore, we suggest that both a lung biopsy and the test of PR3-ANCA (or C-ANCA) should be serially performed in PM/DM patients who have PR3-ANCA (or C-ANCA) and only ILD among systemic manifestations.